Tenaya Therapeutics, Inc. Increase Decrease In Operating Lease Liability
Tenaya Therapeutics, Inc. (TNYA) reported Increase Decrease In Operating Lease Liability of -$1.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-05
- Tenaya Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$740.00K.
- Tenaya Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$713.00K.
- Tenaya Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$697.00K.
- Tenaya Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$683.00K.
- Tenaya Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2025 was -$2.78M.
- Tenaya Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2024 was -$4.12M.
- Tenaya Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2023 was -$4.12M.
- Tenaya Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2022 was -$3.11M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$740.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.45M 10-Q · filed 2026-08-05 | -$2.15M derived: sum of 3 quarters · filed 2026-08-05 | -$2.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$713.00K 10-Q · filed 2026-05-06 | -$1.41M derived: sum of 2 quarters · filed 2026-05-06 | -$2.09M derived: sum of 3 quarters · filed 2026-05-06 | -$2.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$697.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$1.38M derived: sum of 2 quarters · filed 2026-03-11 | -$2.08M derived: sum of 3 quarters · filed 2026-08-05 | -$2.78M 10-K · filed 2026-03-11 |
| 2025-09-30 | -$683.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.38M derived: sum of 2 quarters · filed 2026-08-05 | -$2.08M 10-Q · filed 2025-11-10 | -$3.01M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.40M 10-Q · filed 2026-08-05 | -$2.33M derived: sum of 3 quarters · filed 2026-08-05 | -$3.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$697.00K 10-Q · filed 2026-05-06 | -$1.63M derived: sum of 2 quarters · filed 2026-05-06 | -$2.66M derived: sum of 3 quarters · filed 2026-05-06 | -$3.76M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$1.97M derived: sum of 2 quarters · filed 2026-03-11 | -$3.06M derived: sum of 3 quarters · filed 2026-03-11 | -$4.12M 10-K · filed 2026-03-11 |
| 2024-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.13M derived: sum of 2 quarters · filed 2025-11-10 | -$3.19M 10-Q · filed 2025-11-10 | -$4.26M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.15M 10-Q · filed 2025-08-06 | -$3.22M derived: sum of 3 quarters · filed 2025-08-06 | -$4.28M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$1.06M 10-Q · filed 2025-05-07 | -$2.13M derived: sum of 2 quarters · filed 2025-05-07 | -$3.19M derived: sum of 3 quarters · filed 2025-05-07 | -$4.20M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$2.13M derived: sum of 2 quarters · filed 2025-03-10 | -$3.14M derived: sum of 3 quarters · filed 2025-03-10 | -$4.12M 10-K · filed 2025-03-10 |
| 2023-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$2.08M derived: sum of 2 quarters · filed 2024-11-06 | -$3.06M 10-Q · filed 2024-11-06 | -$4.01M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.00M 10-Q · filed 2024-08-08 | -$2.96M derived: sum of 3 quarters · filed 2024-08-08 | -$3.90M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$979.00K 10-Q · filed 2024-05-14 | -$1.94M derived: sum of 2 quarters · filed 2024-05-14 | -$2.88M derived: sum of 3 quarters · filed 2024-05-14 | -$3.55M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$960.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$1.90M derived: sum of 2 quarters · filed 2024-03-18 | -$2.57M derived: sum of 3 quarters · filed 2024-03-18 | -$3.11M 10-K · filed 2024-03-18 |
| 2022-09-30 | -$941.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.61M derived: sum of 2 quarters · filed 2023-11-08 | -$2.15M 10-Q · filed 2023-11-08 | -$2.67M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$673.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.21M 10-Q · filed 2023-08-09 | -$1.73M derived: sum of 3 quarters · filed 2023-08-09 | -$1.93M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$533.00K 10-Q · filed 2023-05-10 | -$1.05M derived: sum of 2 quarters · filed 2023-05-10 | -$1.26M derived: sum of 3 quarters · filed 2023-05-10 | -$1.62M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$727.00K derived: sum of 2 quarters · filed 2023-03-08 | -$1.09M derived: sum of 3 quarters · filed 2023-03-08 | -$1.47M 10-K · filed 2023-03-08 |
| 2021-09-30 | -$207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$568.00K derived: sum of 2 quarters · filed 2022-11-10 | -$952.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$361.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$745.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | -$384.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |